![]() |
|
|||||||
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share .19 excluding items
* ** revenue was recognized for three months ended June 30,2016 and 2015 ??????? ??????: BRIEF-Sarepta Therapeutics Q2 **n-GAAP loss per share $1.19 excluding items || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|